Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Emerita Announces Commencement of Hearings to Resolve Corruption Charges Related to Awarding of Aznalcollar Public Tender, Spain
-
Ryman Hospitality Properties, Inc. Provides Investor Presentation Ahead of Upcoming Institutional Investor Conferences
-
Lexicon Pharmaceuticals Announces Topline Results from Phase 2b PROGRESS Study Evaluating Pilavapadin (LX9211) in Adults with Diabetic Peripheral Neuropathic Pain
-
Seres Therapeutics Receives Feedback From FDA on SER-155 Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT) Development Approach
-
Aura Biosciences Announces Additional Data from Ongoing Phase 1 Trial in Non-Muscle Invasive Bladder Cancer to be Presented as a Late-Breaking Abstract at the 40th Annual European Association of Urolo
-
Avadel Pharmaceuticals Reiterates 2025 Guidance as it Reports Fourth Quarter and Full Year 2024 Financial Results
-
ArriVent BioPharma Reports Full Year 2024 Financial Results
-
Opthea Announces Phase 2b Wet AMD Publication
-
ScottsMiracle-Gro to Webcast Presentation at Raymond James & Associates 46th Annual Institutional Investors Conference on March 4
-
Neumora Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
-
Ocular Therapeutix™ Reports Fourth Quarter and Full Year 2024 Results and Business Highlights
-
TG Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
-
Giyani Produces First Battery-Grade Manganese at its Demo Plant
-
Ligand to Participate in March Investor Conferences
-
BioXcel Therapeutics Announces FDA Closed its Inspection of Site for Phase 3 TRANQUILITY II Trial for Acute Treatment of Agitation Associated with Alzheimer’s Dementia
-
Voyager Reports Positive Topline Data for Single Ascending Dose (SAD) Trial of Anti-Tau Antibody VY7523 and Initiates Multiple Ascending Dose (MAD) Trial in Alzheimer’s Disease
-
United Lithium Applies to Extend Warrant Expiry Date
-
NewGen and BOBCARE Announce Strategic Collaboration to Expand Fertility Services in Kyrgyzstan
-
CareCloud Reignites Acquisition Strategy with MesaBilling Acquisition
-
Traws Pharma Reports Positive Results from An Accepted Bird Flu Model for Anti-Viral Candidate, Tivoxavir Marboxil
-
Rapport Therapeutics Announces Appointment of Dr. Jeffrey Sevigny as Chief Medical Officer to Drive Clinical Strategy and Precision Medicine Development
-
OROCO CLOSES NON-BROKERED PRIVATE PLACEMENT
-
Bitfarms Provides February 2025 Production and Operations Update
-
Falco Receives Additional Comments and Questions From the Ministry of the Environment on the Horne 5 Project
-
Rubicon Organics to Acquire Cultivation Facility in BC to Strengthen Leadership in Premium Cannabis
-
Interpublic Group Announces Sale of R/GA to Truelink Capital
-
Uphold Relaunches Staking Rewards to Customers in the US
-
Conavi Medical Reports Fiscal Q1 2025 Interim Financial Results and Operational Highlights
-
Axsome Therapeutics Announces FDA Pre-NDA Meeting Minutes for AXS-05 in Alzheimer’s Disease Agitation Supporting NDA Submission
-
ABB to invest $120 million to expand US manufacturing
-
Verrica Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results and Provide a Corporate Update on March 11, 2025
-
Next Hydrogen Solutions Inc. Announces Changes to its Board of Directors
-
PolyPid to Participate in the 37th Annual ROTH Conference
-
Montauk Renewables Schedules Full Year 2024 Conference Call for Thursday, March 13, 2025, at 8:30 a.m. ET
-
Technical Requirements for Titanium Coarse Metal Powder Have Been Met by PyroGenesis’ NexGen™ Plasma Atomized Metal Powder for Global Aerospace OEM
-
ScottsMiracle-Gro to Webcast Presentation at Raymond James & Associates 46th Annual Institutional Investors Conference on March 4
-
Green Thumb Expands Nevada Retail Footprint with the Opening of RISE Dispensary Henderson on Boulder on March 4
-
EDAP Appoints Glen French to Board of Directors
-
Signify share repurchase period update
-
eQ Plc has released the 2024 Annual Report and the Remuneration Policy for Governing Bodies
-
Immunocore to present at upcoming investor conferences
-
Pharvaris Presents Long-Term Clinical Data of Deucrictibant for the Prevention and Treatment of HAE Attacks at the 2025 AAAAI/WAO Joint Congress
-
Eton Pharmaceuticals Announces Commercial Launch of Galzin® (zinc acetate) Capsules
-
Pharvaris to Participate in the Leerink Partners Global Healthcare Conference 2025
-
Fortrea Reports Fourth Quarter and Full-Year 2024 Results; Issues Full-Year 2025 Guidance
-
Blue Moon Announces Robust Results of the Preliminary Economic Assessment for Its Blue Moon VMS Deposit Including an After-Tax Base Case IRR of 38% and 48% Using Spot Prices
-
Bridge Specialty Group completes the acquisition of NBS Insurance Agency, Inc., announces new brand name—introducing LocalEdge
-
MRC Global Provides Update on Timing of Earnings Release and Filing of Form 10-K
-
Affimed to Present at the Leerink Partners Global Healthcare Conference 2025
-
Highwoods Agrees to Acquire Advance Auto Parts Tower in Raleigh
